loader2
Partner With Us NRI

Aster DM Healthcare Ltd share Price Today

Company details

324.05
336.15
294.35
558.00
6M Return -22.92%
1Y Return 6.98%
Mkt Cap.(Cr) 16,578.84
Volume 804,498
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 804,498

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
Numbers driven by strong GCC performance…
About The Stock

    Aster operates a network of hospitals, clinics, retail pharmacies in several GCC countries as well as India.

    • Its network consists of 15 hospitals, 113 clinics and 257 retail pharmacies in GCC states;15 hospitals, 12 clinics and 177 labs in India; total bed capacity: GCC: 1441, India: 4095
    • Revenue break-up Q3FY23: hospitals: 55%, pharmacies: 25%, clinics: 20% with GCC & India contributing 78% & 22% of revenues, respectively
Q3FY23

    Strong numbers propelled by GCC.

    • Revenues grew 13.3% QoQ to ₹ 3192 crore driven by 17.3% QoQ growth in the GCC business to ₹ 2550 crore. India was steady with 1.7% QoQ growth to ₹ 735 crore
    • EBITDA margins improved 273 bps QoQ to 14.1% while EBITDA grew 40.7% QoQ to ₹ 449 crore
    • Subsequently, net profit increased 201.6% QoQ to ₹ 139 crore

Click here for full recommendation

Research view on more stocks

Healtcare Services company Aster DM Healthcare announced Q4FY24 & FY24 results:

  • Revenue:
    • Revenue grew 24% YoY to Rs 3,699 crore in FY24 Vs. Rs 2,983 crore in FY23.
    • Revenue grew 22% YoY to Rs 978 crore in Q4FY24 Vs. Rs 804 crore in Q4FY23.
  • EBITDA:
    • Operating EBITDA grew 30% YoY to Rs 620 crore in FY24 Vs. Rs 477 crore in FY23.
    • Operating EBITDA grew 24% YoY to Rs 167 crore in Q4FY24 Vs. Rs 135 crore in Q4FY23.
  • Profits:
    • PBT grew by 34% YoY to Rs 281 crore in FY24 Vs. Rs 210 crore In FY23.
    • Adjusted PAT grew by 63% YoY to Rs 240 crore In FY24 Vs. Rs 147 crore In FY23.
    • Reported PAT grew by 28% YoY to Rs 188 crore in FY24 Vs. Rs 147 crore in FY23.
  • Dividend:
    • For financial year 2024, the Board recommended a 20% final dividend of Rs 2.0 /- (face value of Rs 10 each) per equity share. The dividend is subject to the approval of shareholders in the Annual General Meeting (AGM) of the Company

Commenting on the update on GCC segregation and performance for Q4 and full year FY24, Azad Moopen, Founder and Chairman, Aster DM Healthcare, said: “I am pleased to announce that we have successfully completed the segregation of our India and GCC businesses, obtaining all necessary regulatory approvals and fulfilling the conditions diligently. I want to express my deepest appreciation to all our stakeholders for their support in ushering in a new era to shape Aster India's future. The segregation has allowed us to tailor our strategies to the distinct growing needs of these geographies and position us to seize the unprecedented growth opportunities in the Indian healthcare market.

In FY24, our India business showcased a remarkable 24% YoY revenue growth, surging to Rs 3,699 crores, aided by an increase in bed capacity of 550 beds and ARPOB growth of 10% in FY24. The Operating EBITDA grew by 30% YoY to Rs.620 crores, supported by the better performance of our mature hospitals delivering 22.4% Operating EBITDA margin in FY24,”

Dr. Moopen further added, “I am also pleased to share that we have been conferred with the title of 'Hospital Chain of the Year' at the ET Healthcare Award and Financial Express Healthcare Awards for the year FY23-24. Additionally, Aster Medcity (Kochi) and Aster CMI (Bengaluru) are ranked among top multispecialty hospitals across India by Times of India, Outlook, Newsweek and The Week. As we progress on our journey, we are on track to add ~1700 beds to reach to 6,500 beds by FY27 through a prudent mix of brownfield and greenfield projects which will result in our Aster Medcity and Aster CMI hospitals expanding to 950 beds and 850 beds respectively. This move demonstrates our unwavering dedication to reinforcing our prominent position among India's top healthcare providers. We are happy to have closed the year with Aster India leading the growth metrics across the healthcare peers in the country. We are committed to continuing on this trajectory as the company embarks on a new chapter of future growth.”

Result PDF

View Other Company Results

Aster DM Healthcare Ltd shares SWOT Analysis

Strengths (2)

  • Company with Low Debt
  • High dividends, with rising dividend yields over last five years

Weakness (11)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (0)

Data not found

Threats (4)

  • Red Flag: Large Swings Between Profit and Loss
  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 337.4
R2 342.8
R3 349.5
Pivot

330.70

S1 325.3
S2 318.6
S3 313.2
EMA SMA
336.0
351.6
369.0
368.3
336.9
349.2
385.5
388.3
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
MORGAN STANLEY ASIA SINGAPORE PTE Bulk Purchase 2024-06-21 340 6666030 BSE
FRANKLIN TEMPLETON MUTUAL FUND Bulk Purchase 2024-06-21 340 3157002 BSE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2024-06-21 361.64 2732106 NSE
Name Category Shares
Union Investments Private Limited PROMOTER 37.41%
Union (Mauritius) Holdings Limited PROMOTER 4%

OUR RESEARCH VIEW

Investment recommendation
Numbers driven by strong GCC performance…
Call Date
15 Feb 2023
Entry Price 210.00
Target Price 280.00
Duration
12-18 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Aster DM Healthcare Ltd Stocks COMPARISON

Financials( in Cr) Aster DM Healthcare Ltd Apollo Hospitals Enterprise Ltd Max Healthcare Institute Ltd Fortis Healthcare Ltd Global Health Ltd
Price 331.90 6,664.55 948.50 509.80 1,203.95
% Change 1.95 4.37 2.38 1.27 -0.09
Mcap Cr 16,578.84 95,826.23 92,185.85 38,487.76 32,326.90
Revenue TTM Cr 11,932.88 16,612.50 4,831.37 7,175.67 2,280.01
Net Profit TTM Cr 475.49 887.50 1,103.51 645.22 360.89
PE TTM 135.49 106.80 87.17 65.99 67.46
1 Year Return 6.98 27.86 55.26 49.90 68.29
ROCE 9.22 14.16 13.85 9.65 17.19
ROE 12.43 15.04 16.12 7.81 13.52
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 4,448.07 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 3,555.27 41,445.87
LAST 3M 81,242.17 56,953.52
LAST 6M 176,360.83 56,552.99
LAST 12M 304,497.96 86,223.40
Aster DM Healthcare to table results

Jul 26, 2024 l BSE Announcement

Aster DM Healthcare Limited - Board Meeting

Jul 26, 2024 l NSE Announcement

Aster DM Healthcare Limited - Acquisition

Jul 22, 2024 l NSE Announcement

Date Action Type Ratio
Aug 22, 2024 Dividend 20
Apr 23, 2024 Dividend 1180

Aster DM Healthcare Ltd Information

Stock PE (TTM)
135.49
Promoter Holding
41.88%
Book Value
91.2846
ROCE
9.22%
ROE
12.43%
Description
  • Aster DM Healthcare Ltd. is an Indian conglomerate healthcare provider. It operates medical centres, diagnostic centres, laboratories, hospitals, and pharmacies in the Middle East and India. The company was incorporated in 1987 with headquarters in Dubai, UAE. During FY 2021-2022, Aster DM Healthcare Ltd. Reported a total revenue of Rs 10,303.94 crore, up 19.01% against Rs 8,658.40 crore recorded in the previous financial year, 2020-2021. On 14 October 2022, the company’s market capitalisation stood at Rs 12,080 crore.

    The company is listed on the Bombay Stock Exchange with the code 540975, and on the National Stock Exchange with the code ASTERDM.

    Aster DM Healthcare Ltd. provides services in areas like dental, diabetology, general medicine, cardiology, dermatology, endocrinology, dietetics, ENT, general surgery, neurology, orthopaedics, psychiatry, gynaecology, gastroenterology, ophthalmology, paediatrics, pulmonology, and urology. The company was formerly called Dr Moopen Group and changed its name to DM Healthcare Ltd. in 2008.

    On 30 June 2022, the company’s shareholding pattern showed a 37.88% promoter stake, 11.44% foreign institutional investor stake, 9.65% domestic institutional investor stake, and 40.57% public stake. Union Investments Pvt Ltd. is the leading promoter with a 37.41% stake. In the June 2022 quarter, the promoters’ pledge remained unchanged at 10.44% of the holdings, while mutual fund holdings increased from 8.12% to 9.62%.

    The founder of Aster DM Healthcare Ltd. is Mr Azad Moopen. The company’s leadership team comprises Ms Fara Siddiqui, Dr Malathi Arshanapalai, Mr Veneeth Purushotaman, Dr Shanila Laiju, Mr Brandon Rowberry, Mr N S Balasubramanian, Mr T J Wilson, Ms Alisha Moopen, and Mr Sreenath P Reddy. Its auditors are Deloitte Haskins & Sells. As of 30 June 2022, the company had a total of 49.95 crore shares outstanding.

    On 14 October 2022, the company’s share price closed at Rs 241.90 on BSE. It closed at Rs 241.85 on NSE. Aster DM Healthcare Ltd.’s 52-week high share price was Rs 265.55, and the 52-week low share price was Rs 158.

    The company’s peers include Apollo Hospitals Enterprises Ltd., Max Healthcare Institute Ltd., Fortis Healthcare Ltd., and Dr Lal PathLabs Ltd.

    As of September 2022, HDFC Small Cap Fund had a 3.01% stake in the company. SBI Contra Fund, ICICI Prudential Smallcap Fund, and HDFC Children’s Gift Fund had 2.19%, 1.83%, and 1.49% stakes, respectively.

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose

Registered Address

IX/475L Aster Medcity, Kuttisahib Road Cheranalloore, Kochi, Kerala, 682027

Tel : 91-0484-6699228
Email : cs:asterdmhealthcare.com
Website : http://www.asterdmhealthcare.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 540975
NSE Code : ASTERDM
Book Closure Date (Month) :
BSE Group : A
ISIN : INE914M01019

FAQ’s on Aster DM Healthcare Ltd Shares

You can buy Aster DM Healthcare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Aster DM Healthcare Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 26, 2024 04:12 PM the closing price of Aster DM Healthcare Ltd was Rs.331.90.

The latest PE ratio of Aster DM Healthcare Ltd as of Jul 26, 2024 04:12 PM is 135.49

The latest PB ratio of Aster DM Healthcare Ltd as of Jul 26, 2024 04:12 PM is 0.28

The 52-week high of Aster DM Healthcare Ltd share price is Rs. 558.00 while the 52-week low is Rs. 294.35

According to analyst recommendations, Aster DM Healthcare Ltd Share has a "Buy" rating for the long term.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 26, 2024 04:12 PM, the market cap of Aster DM Healthcare Ltd stood at Rs. 16,578.84 Cr.

Download App

Download Our App

Play Store App Store
market app